Comparing Various In Vitro Prediction Criteria to Assess the Potential of a New Molecular Entity to Inhibit Organic Anion Transporting Polypeptide 1B1-Reference-Cited by-同舟云学术

Comparing Various In Vitro Prediction Criteria to Assess the Potential of a New Molecular Entity to Inhibit Organic Anion Transporting Polypeptide 1B1

Published:2016-07 Issue: Volume:56 Page:S59-S72
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Vaidyanathan Jayabharathi¹,Yoshida Kenta¹²,Arya Vikram¹,Zhang Lei¹

Affiliation:

1. Office of Clinical Pharmacology, Office of Translational Sciences; Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring MD

2. Oak Ridge Institution for Science and Education (ORISE) Fellow

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference46 articles.

1. Transporter-mediated drug interactions: clinical implications and in vitro assessment;Lin;Expert Opin Drug Metab Toxicol,2007

2. Transporter-mediated drug-drug interactions;Muller;Pharmacogenomics,2011

3. The role of transporters in drug interactions;Endres;Eur J Pharm Sci,2006

4. Membrane transporters in drug development;Giacomini;Nat Rev Drug Discov.,2010

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preincubation-dependent inhibition of organic anion transporting polypeptide 2B1;European Journal of Pharmaceutical Sciences;2024-09

2. Coproporphyrin‐I as a Selective OATP1B Biomarker Can Be Used to Delineate the Mechanisms of Complex Drug–Drug Interactions: Cedirogant Case Study;Clinical Pharmacology & Therapeutics;2024-08-05

3. Innovative Approaches to Optimize Clinical Transporter Drug–Drug Interaction Studies;Pharmaceutics;2024-07-26

4. Expanding Role of Endogenous Biomarkers for Assessment of Transporter Activity in Drug Development: Current Applications and Future Horizon;Pharmaceutics;2024-06-25

5. Evaluation of the Clinical Drug‐Drug Interaction Potential of Pritelivir on Transporters and CYP450 Enzymes Using a Cocktail Approach;Clinical Pharmacology in Drug Development;2024-05-16